rm(list = ls())

### Decision tree for cost-effectiveness of new pathway for paediatric monogenic obesity. 

#install.packages("BCEA")
library(BCEA)
library(ggplot2)


set.seed(2025)

#Define N of samples for probabilistic analysis 

n_samples<-10000


#Treatment decision - further or no further examination

n_treat=2
t_names=c("No further examination","Further examination")

#########

# Define scenarios for deterministic sensitivity analysis
dsa_scenarios <- list(
  
  list(
    name = "High e_resolved, Low e_unresolved",
    e_resolved_params = list(mean = 0.85, sd = 0.085),
    e_unresolved_params = list(mean = 0.2, sd = 0.02)
  ),
  list(
    name = "Low e_resolved, High e_unresolved",
    e_resolved_params = list(mean = 0.4, sd = 0.04),
    e_unresolved_params = list(mean = 0.3, sd = 0.03)
  )
)


# Function to run DSA for a given scenario
run_dsa_scenarios <- function(scenarios) {
  all_results <- list()  # Create a list to store results for each scenario
  
  for (scenario in scenarios) {
    # Generate e_resolved and e_unresolved based on scenario parameters
    e_resolved <- rnorm(n = n_samples, mean = scenario$e_resolved_params$mean, sd = scenario$e_resolved_params$sd)
    e_unresolved <- rnorm(n = n_samples, mean = scenario$e_unresolved_params$mean, sd = scenario$e_unresolved_params$sd)
    
    # Update effects calculations (same as before)
    effects <- (p_resolved * e_resolved) + 
      (p_unresolved * e_unresolved) +
      ((p_exam_normal * p_resolved) * e_resolved) +
      ((p_exam_normal * p_unresolved) * e_unresolved) +
      ((p_exam_abnormal * p_development_abnormal * p_growth_abnormal * p_array_normal * p_array_wgs_r149_resolved) * e_resolved) +
      ((p_exam_abnormal * p_development_abnormal * p_growth_abnormal * p_array_normal * p_array_wgs_r149_unresolved) * e_unresolved) +
      ((p_exam_abnormal * p_development_abnormal * p_growth_abnormal * p_array_abnormal * p_growthabnormalarray_resolved) * e_resolved) +
      ((p_exam_abnormal * p_development_abnormal * p_growth_abnormal * p_array_abnormal * p_growthabnormalarray_unresolved) * e_unresolved) +
      ((p_exam_normal * p_development_abnormal * p_growth_normal * p_array_normal * p_growthnormal_array_wgs_r149_resolved) * e_resolved) +
      ((p_exam_normal * p_development_abnormal * p_growth_normal * p_array_normal * p_growthnormal_array_wgs_r149_unresolved) * e_unresolved) +
      ((p_exam_abnormal * p_development_abnormal * p_growth_normal * p_array_abnormal * p_arrayabnormal_resolved) * e_resolved) +
      ((p_exam_abnormal * p_development_abnormal * p_growth_normal * p_array_abnormal * p_arrayabnormal_unresolved) * e_unresolved) +
      ((p_exam_normal * p_development_normal * p_r149_resolved) * e_resolved) +
      ((p_exam_normal * p_development_normal * p_r149_unresolved) * e_unresolved)
    
    # Use BCEA to calculate cost-effectiveness
    bcea_examine <- bcea(effects, costs, ref = 2, interventions = t_names, Kmax = 30000)
    
    # Extract mean effects and costs
    mean_effects <- colMeans(bcea_examine$e)
    mean_costs <- colMeans(bcea_examine$c)
    
    # Display the results
    print(mean_effects)
    print(mean_costs)
    
    # Generate summary results
    summary_results <- summary(bcea_examine, wtp = 30000)
    
    # Save the results for this scenario
    scenario_results <- list(
      scenario_name = scenario$name,
      summary = summary_results
    )
    
    # Add the results to the list of all results
    all_results[[scenario$name]] <- scenario_results
  }
  
  return(all_results)
}

########################## Costs - see related tables in Word and PowerPoint ########################## 

##Code to update CPRD costs to 2022/23 prices from 2021/22 prices - inflated using NHS Cost Inflation Index (NHSCII) from PSSRU 
#Jones, Karen C., Weatherly, Helen, Birch, Sarah, Castelli, Adriana, Chalkley, Martin, Dargan, Alan, Forder, Julien E., Gao, Minyue, Hinde, Seb, Markham, Sarah and others (2024) Unit Costs of Health and Social Care 2023 Manual. Technical report. Personal Social Services Research Unit (University of Kent) & Centre for Health Economics (University of York), Kent, UK 10.22024/UniKent/01.02.105685 <https://doi.org/10.22024/UniKent%2F01.02.105685>

c_inflate=1.07
c_resolved=1329*c_inflate
c_resolved
c_unresolved=1605*c_inflate
c_unresolved
c_SOC=354*c_inflate
c_SOC

c_exam <- t(matrix(rep(c(0, 217), n_samples), ncol = n_samples, nrow = n_treat))  

c_SOC=rnorm(n=n_samples,mean=379,sd=38)    


c_resolved=rnorm(n=n_samples,mean=1422,sd=142) ##noted 6 january - update with real data

c_unresolved=rnorm(n=n_samples,mean=1717,sd=171) ## ##noted 6 january - update with real data

c_array_CGH_SNP=cbind(rep(0,n_samples),rnorm(n=n_samples, mean=320,sd=16))

c_WGS=cbind(rep(0,n_samples),rnorm(n=n_samples,mean=1000,sd=100))
c_R149=cbind(rep(0,n_samples),rnorm(n=n_samples,mean=650,65))

c_semaglutide=rep(c(0,879),length.out = n_samples) # this is based on 1mg of the drug costing 73.25 per month

##Effectiveness - are these parameters used - check re new function noted 7 January

e_resolved=rnorm(n=n_samples,mean=0.6,sd=.06)

e_unresolved=rnorm(n=n_samples,mean=0.2,sd=0.02)



########################## Probabilities ########################## 


##Function to output desired means of a beta distribution

calculate_shape_parameters <- function(desired_mean) {
  # Set an arbitrary value for one of the shape parameters 
  alpha <- 1
  
  # Calculate beta using the formula
  beta <- alpha / desired_mean - alpha
  
  # Return the calculated shape parameters
  return(list(alpha = alpha, beta = beta))
}

# Example:
desired_mean <- 0.9
shape_params <- calculate_shape_parameters(desired_mean)
cat("For a desired mean of", desired_mean, "the calculated shape parameters are:\n")
cat("Alpha:", shape_params$alpha, "\n")
cat("Beta:", shape_params$beta, "\n")

##need to create the probabilities as matrices to take the results of each model run

p_resolved <- p_unresolved <- matrix(nrow = n_samples, ncol = n_treat) ##Comment - this relates only to first decision and should be zero for col 2 since this
#is for treatment (ie further examination) arm

# Probabilities for no exam follow beta distribution - this will populate the first column of the matrices just created
p_resolved[, 1] <- rbeta(n = n_samples,  shape1 = 1,  shape2 = 9) ##parameters based on a desired mean of 0.1 per conversations with clinical team
p_resolved[,2]<-0

p_unresolved[,1]<-1-p_resolved[,1]
p_unresolved[,2]<-0


###
p_array_wgs_r149_resolved<-p_array_wgs_r149_unresolved<-matrix(nrow = n_samples, ncol = n_treat) ##based on mean of 80% 

p_array_wgs_r149_resolved[,1]<-0
p_array_wgs_r149_unresolved[,1]<-0

p_array_wgs_r149_resolved[,2]<-rbeta(n = n_samples,  shape1 = 1,  shape2 = 0.25) ##based on mean of 80% 
p_array_wgs_r149_unresolved[,2]<-1-p_array_wgs_r149_resolved[,2] 

###
p_growthabnormalarray_resolved<-p_growthabnormalarray_unresolved<-matrix(nrow = n_samples, ncol = n_treat)

p_growthabnormalarray_resolved[,1]<-0
p_growthabnormalarray_unresolved[,1]<-0

p_growthabnormalarray_resolved[,2]<-rbeta(n = n_samples,  shape1 = 1,  shape2 = 0.25) ##based on mean of 80% 
p_growthabnormalarray_unresolved[,2]<-1-p_growthabnormalarray_resolved[,2] 

###
p_growthnormal_array_wgs_r149_resolved<-p_growthnormal_array_wgs_r149_unresolved<-matrix(nrow = n_samples, ncol = n_treat)

p_growthnormal_array_wgs_r149_resolved[,1]<-0
p_growthnormal_array_wgs_r149_unresolved[,1]<-0

p_growthnormal_array_wgs_r149_resolved[,2]<-rbeta(n = n_samples,  shape1 = 1,  shape2 = 0.25) ##based on mean of 80% 
p_growthnormal_array_wgs_r149_unresolved[,2]<-1-p_growthnormal_array_wgs_r149_resolved[,2]

###
p_arrayabnormal_resolved<-p_arrayabnormal_unresolved<-matrix(nrow = n_samples, ncol = n_treat)

p_arrayabnormal_resolved[,1]<-0
p_arrayabnormal_unresolved[,1]<-0

p_arrayabnormal_resolved[,2]<-rbeta(n = n_samples,  shape1 = 1,  shape2 = 0.25) ##based on mean of 80% 
p_arrayabnormal_unresolved[,2]<-1-p_arrayabnormal_resolved[,2]

###

p_r149_resolved<-p_r149_unresolved<-matrix(nrow = n_samples, ncol = n_treat)

p_r149_resolved[,1]<-0
p_r149_unresolved[,1]<-0

p_r149_resolved[,2]<-rbeta(n = n_samples,  shape1 = 1,  shape2 = 0.25)  ##based on mean of 80% 
p_r149_unresolved[,2]<-1-p_r149_resolved[,2]

####Other probabilities 


p_exam_normal<-p_exam_abnormal<-matrix(nrow = n_samples, ncol = n_treat)

p_exam_normal<-p_exam_abnormal<-matrix(nrow = n_samples, ncol = n_treat)

p_exam_normal[,1]<-0
p_exam_abnormal[,1]<-0
#
p_exam_normal[,2]<-rbeta(n = n_samples,  shape1 = 1,  shape2 = 0.67)  ##based on mean of 60% 
p_exam_abnormal[,2]<-1-p_exam_normal[,2]


###

p_development_normal<-p_development_abnormal<-matrix(nrow = n_samples, ncol = n_treat)

p_development_normal[,1]<-0
p_development_abnormal[,1]<-0

p_development_normal[,2]<-rbeta(n = n_samples,  shape1 = 1,  shape2 = 0.67) ##based on mean of 60%
p_development_abnormal[,2]<-1-p_development_normal[,2]


###
p_growth_normal<-p_growth_abnormal<-matrix(nrow = n_samples, ncol = n_treat)

p_growth_normal[,1]<-0
p_growth_abnormal[,1]<-0

p_growth_normal[,2]<-rbeta(n = n_samples,  shape1 = 1,  shape2 = 0.11) ##based on mean of 90%
p_growth_abnormal[,2]<-1-p_growth_normal[,2]



###

p_array_normal<-p_array_abnormal<-matrix(nrow = n_samples, ncol = n_treat)

p_array_normal[,1]<-0
p_array_abnormal[,1]<-0

p_array_normal[,2]<-rbeta(n = n_samples,  shape1 = 1,  shape2 = 0.17) ##based on mean of 0.85%
p_array_abnormal[,2]<-1-p_array_normal[,2]




########################## Write out equations for total cost and total effects - see related information in paper and Powerpoint ########################## 

(costs<-c_exam+(p_resolved*c_SOC) #1
              +(p_unresolved*c_SOC)# 2
              +((p_exam_normal*p_resolved)*(c_SOC+c_resolved))#3
              +((p_exam_normal*p_unresolved)*(c_SOC+c_unresolved))#4
              +((p_exam_abnormal*p_development_abnormal*p_growth_abnormal*p_array_normal*p_array_wgs_r149_resolved)*(c_array_CGH_SNP+c_WGS+c_resolved+c_semaglutide))#5
              +((p_exam_abnormal*p_development_abnormal*p_growth_abnormal*p_array_normal*p_array_wgs_r149_unresolved)*(c_array_CGH_SNP+c_WGS+c_R149+c_unresolved+c_semaglutide))#6
              +((p_exam_abnormal*p_development_abnormal*p_growth_abnormal*p_array_abnormal*p_growthabnormalarray_resolved)*(c_array_CGH_SNP+c_resolved+c_semaglutide ))#7
              +((p_exam_abnormal*p_development_abnormal*p_growth_abnormal*p_array_abnormal*p_growthabnormalarray_unresolved)*(c_array_CGH_SNP+c_unresolved+c_semaglutide))#8
              +((p_exam_normal*p_development_abnormal*p_growth_normal*p_array_normal*p_growthnormal_array_wgs_r149_resolved)*(c_array_CGH_SNP+c_WGS+c_R149+c_resolved+c_semaglutide))#9
              +((p_exam_normal*p_development_abnormal*p_growth_normal*p_array_normal*p_growthnormal_array_wgs_r149_unresolved)*(c_array_CGH_SNP+c_WGS+c_R149+c_unresolved+c_semaglutide))#10
              +((p_exam_abnormal*p_development_abnormal*p_growth_normal*p_array_abnormal*p_arrayabnormal_resolved)*(c_array_CGH_SNP+c_resolved+c_semaglutide))#11
              +((p_exam_abnormal*p_development_abnormal*p_growth_normal*p_array_abnormal*p_arrayabnormal_unresolved)*(c_array_CGH_SNP+c_unresolved+c_semaglutide))#12
              +((p_exam_normal*p_development_normal*p_r149_resolved)*(c_R149+c_resolved+c_semaglutide))#13
              +((p_exam_normal*p_development_normal*p_r149_unresolved)*(c_R149+c_unresolved+c_semaglutide))#14
  
)

(effects<-
            (p_resolved*e_resolved) #1
            +(p_unresolved*e_unresolved)# 2
            +((p_exam_normal*p_resolved)*(e_resolved))#3
            +((p_exam_normal*p_unresolved)*(e_unresolved))#4
            +((p_exam_abnormal*p_development_abnormal*p_growth_abnormal*p_array_normal*p_array_wgs_r149_resolved)*(e_resolved))#5
            +((p_exam_abnormal*p_development_abnormal*p_growth_abnormal*p_array_normal*p_array_wgs_r149_unresolved)*(e_unresolved))#6
            +((p_exam_abnormal*p_development_abnormal*p_growth_abnormal*p_array_abnormal*p_growthabnormalarray_resolved)*(e_resolved ))#7
            +((p_exam_abnormal*p_development_abnormal*p_growth_abnormal*p_array_abnormal*p_growthabnormalarray_unresolved)*(e_unresolved))#8
            +((p_exam_normal*p_development_abnormal*p_growth_normal*p_array_normal*p_growthnormal_array_wgs_r149_resolved)*(e_resolved))#9
            +((p_exam_normal*p_development_abnormal*p_growth_normal*p_array_normal*p_growthnormal_array_wgs_r149_unresolved)*(e_unresolved))#10
            +((p_exam_abnormal*p_development_abnormal*p_growth_normal*p_array_abnormal*p_arrayabnormal_resolved)*(e_resolved))#11
            +((p_exam_abnormal*p_development_abnormal*p_growth_normal*p_array_abnormal*p_arrayabnormal_unresolved)*(e_unresolved))#12
            +((p_exam_normal*p_development_normal*p_r149_resolved)*(e_resolved))#13
            +((p_exam_normal*p_development_normal*p_r149_unresolved)*(e_unresolved))#14
            
          )

########################## Process results of the model ########################## 

# Can use the colMeans() function to get a quick look at the point estimate results. 
colMeans(costs)
colMeans(effects)

#Use BCEA to get full results

bcea_examine <- bcea(effects, costs, ref = 2, interventions = t_names, Kmax = 30000)

summary(bcea_examine,wtp=30000)
ce_plot = ceplane.plot(bcea_examine,
                       graph = "ggplot2",
                       wtp = 30000,
                       title = NULL,
                       ylab = "Incremental costs (£)",
                       xlab = "Incremental QALYs") 


print(ce_plot)


##get gridlines


ggsave("C:/Users/padra/Downloads/ceplane_plot.png", plot = ce_plot, width = 10, height = 8, dpi = 300)

# Generate the Cost-Effectiveness Acceptability Curve Plot
ceac_plot <- ceac.plot(bcea_examine, 
                       graph = "ggplot2", 
                       line = list(color = "red")) +
  scale_x_continuous(breaks = seq(0, 30000, by = 5000)) +  # Set x-axis breaks
  scale_y_continuous(breaks = seq(0, 1, by = 0.25), limits = c(0, 1)) +  # Set y-axis breaks and range
  labs(
    x = "Cost-effectiveness threshold (£)", 
    y = "Probability of being cost-effective"  
  ) +
  ggtitle("") +  # Set an empty title
  theme(
    panel.grid.major.x = element_line(color = "grey80", linewidth =  0.5),  # Customize vertical gridlines
    panel.grid.major.y = element_line(color = "grey80", linewidth =  0.5),  # Customize horizontal gridlines
    panel.grid.minor.x = element_blank(),  # Remove minor vertical gridlines
    panel.grid.minor.y = element_blank()   # Remove minor horizontal gridlines
  )

# Print and save the CEAC plot
print(ceac_plot)



ggsave("C:/Users/padra/Downloads/ceac_plot.png", plot = ceac_plot, width = 10, height = 8, dpi = 300)

# Run DSA for all defined scenarios
all_scenarios_results <- run_dsa_scenarios(dsa_scenarios)

